SWOG clinical trial number
SWOG-8004

Evaluation of DHAD in Soft Tissue and Bone Sarcomas

Closed
Phase
Published
Abbreviated Title
Evaluation of DHAD in Soft Tissue and Bone Sarcomas
Activated
07/03/1980
Closed
07/28/1981

Publication Information Expand/Collapse

1985

Phase II trial of mitoxantrone in advanced sarcomas: A Southwest Oncology Group study.

FE Bull;DD Von Hoff;SP Balcerzak;RL Stephens;FJ Panettiere Cancer Treat Rep 69:231-233

1983

Southwest Oncology Group Phase II studies with Mitoxantrone in nonhematologic malignancies.

RL Stephens;DD Von Hoff;SA Taylor;WA Knight III;RB Livingston;FE Bull;J Cowan;RD Hilgers;CK Osborne;GA Gates;G Clark In: New Anticancer Drugs: Mitoxantrone and Bisantrene . M Rozencweig, et al, eds. New York: Raven Press, 125-30

Cardiotoxicity in patients treated with Mitoxantrone on Southwest Oncology Group Phase II protocols.

GM Clark;LK Tokaz;DD Von Hoff;LL Thoi;CA Coltman Jr Cancer Treat Symp 3:25-30

1981

Southwest Oncology Group (SWOG) Phase II with mitoxantrone in non-hematologic malignancies.

RL Stephens;G Clark 3rd NCI-EORTC Symposium on New Drugs in Cancer Therapy (October 15-17, 1981), #36